267 related articles for article (PubMed ID: 21289244)
1. Somatic mutation and germline sequence abnormalities in CDKN1B, encoding p27Kip1, in sporadic parathyroid adenomas.
Costa-Guda J; Marinoni I; Molatore S; Pellegata NS; Arnold A
J Clin Endocrinol Metab; 2011 Apr; 96(4):E701-6. PubMed ID: 21289244
[TBL] [Abstract][Full Text] [Related]
2. Germline and somatic mutations in cyclin-dependent kinase inhibitor genes CDKN1A, CDKN2B, and CDKN2C in sporadic parathyroid adenomas.
Costa-Guda J; Soong CP; Parekh VI; Agarwal SK; Arnold A
Horm Cancer; 2013 Oct; 4(5):301-7. PubMed ID: 23715670
[TBL] [Abstract][Full Text] [Related]
3. Loss of p27 expression is associated with MEN1 gene mutations in sporadic parathyroid adenomas.
Borsari S; Pardi E; Pellegata NS; Lee M; Saponaro F; Torregrossa L; Basolo F; Paltrinieri E; Zatelli MC; Materazzi G; Miccoli P; Marcocci C; Cetani F
Endocrine; 2017 Feb; 55(2):386-397. PubMed ID: 27038812
[TBL] [Abstract][Full Text] [Related]
4. Germline CDKN1B/p27Kip1 mutation in multiple endocrine neoplasia.
Georgitsi M; Raitila A; Karhu A; van der Luijt RB; Aalfs CM; Sane T; Vierimaa O; Mäkinen MJ; Tuppurainen K; Paschke R; Gimm O; Koch CA; Gündogdu S; Lucassen A; Tischkowitz M; Izatt L; Aylwin S; Bano G; Hodgson S; De Menis E; Launonen V; Vahteristo P; Aaltonen LA
J Clin Endocrinol Metab; 2007 Aug; 92(8):3321-5. PubMed ID: 17519308
[TBL] [Abstract][Full Text] [Related]
5. The parathyroid/pituitary variant of multiple endocrine neoplasia type 1 usually has causes other than p27Kip1 mutations.
Ozawa A; Agarwal SK; Mateo CM; Burns AL; Rice TS; Kennedy PA; Quigley CM; Simonds WF; Weinstein LS; Chandrasekharappa SC; Collins FS; Spiegel AM; Marx SJ
J Clin Endocrinol Metab; 2007 May; 92(5):1948-51. PubMed ID: 17299066
[TBL] [Abstract][Full Text] [Related]
6. A heterozygous frameshift mutation in exon 1 of CDKN1B gene in a patient affected by MEN4 syndrome.
Tonelli F; Giudici F; Giusti F; Marini F; Cianferotti L; Nesi G; Brandi ML
Eur J Endocrinol; 2014 Aug; 171(2):K7-K17. PubMed ID: 24819502
[TBL] [Abstract][Full Text] [Related]
7. Genetic and epigenetic changes in sporadic endocrine tumors: parathyroid tumors.
Costa-Guda J; Arnold A
Mol Cell Endocrinol; 2014 Apr; 386(1-2):46-54. PubMed ID: 24035866
[TBL] [Abstract][Full Text] [Related]
8. Multiple endocrine neoplasia type 4.
Lee M; Pellegata NS
Front Horm Res; 2013; 41():63-78. PubMed ID: 23652671
[TBL] [Abstract][Full Text] [Related]
9. MEN1 intragenic deletions may represent the most prevalent somatic event in sporadic primary hyperparathyroidism.
Alvelos MI; Vinagre J; Fonseca E; Barbosa E; Teixeira-Gomes J; Sobrinho-Simões M; Soares P
Eur J Endocrinol; 2013 Feb; 168(2):119-28. PubMed ID: 23093699
[TBL] [Abstract][Full Text] [Related]
10. Molecular pathogenesis of primary hyperparathyroidism.
Arnold A; Shattuck TM; Mallya SM; Krebs LJ; Costa J; Gallagher J; Wild Y; Saucier K
J Bone Miner Res; 2002 Nov; 17 Suppl 2():N30-6. PubMed ID: 12412775
[TBL] [Abstract][Full Text] [Related]
11. Aryl hydrocarbon receptor interacting protein (AIP) mutations occur rarely in sporadic parathyroid adenomas.
Pardi E; Marcocci C; Borsari S; Saponaro F; Torregrossa L; Tancredi M; Raspini B; Basolo F; Cetani F
J Clin Endocrinol Metab; 2013 Jul; 98(7):2800-10. PubMed ID: 23633209
[TBL] [Abstract][Full Text] [Related]
12. Whole-exome sequencing studies of nonhereditary (sporadic) parathyroid adenomas.
Newey PJ; Nesbit MA; Rimmer AJ; Attar M; Head RT; Christie PT; Gorvin CM; Stechman M; Gregory L; Mihai R; Sadler G; McVean G; Buck D; Thakker RV
J Clin Endocrinol Metab; 2012 Oct; 97(10):E1995-2005. PubMed ID: 22855342
[TBL] [Abstract][Full Text] [Related]
13. Novel germline variants of CDKN1B and CDKN2C identified during screening for familial primary hyperparathyroidism.
Mazarico-Altisent I; Capel I; Baena N; Bella-Cueto MR; Barcons S; Guirao X; Albert L; Cano A; Pareja R; Caixàs A; Rigla M
J Endocrinol Invest; 2023 Apr; 46(4):829-840. PubMed ID: 36334246
[TBL] [Abstract][Full Text] [Related]
14. Analysis of Activating GCM2 Sequence Variants in Sporadic Parathyroid Adenomas.
Riccardi A; Aspir T; Shen L; Kuo CL; Brown TC; Korah R; Murtha TD; Bellizzi J; Parham K; Carling T; Costa-Guda J; Arnold A
J Clin Endocrinol Metab; 2019 Jun; 104(6):1948-1952. PubMed ID: 30624640
[TBL] [Abstract][Full Text] [Related]
15. Functional characterization of a rare germline mutation in the gene encoding the cyclin-dependent kinase inhibitor p27Kip1 (CDKN1B) in a Spanish patient with multiple endocrine neoplasia-like phenotype.
Malanga D; De Gisi S; Riccardi M; Scrima M; De Marco C; Robledo M; Viglietto G
Eur J Endocrinol; 2012 Mar; 166(3):551-60. PubMed ID: 22129891
[TBL] [Abstract][Full Text] [Related]
16. Germ-line mutations in p27Kip1 cause a multiple endocrine neoplasia syndrome in rats and humans.
Pellegata NS; Quintanilla-Martinez L; Siggelkow H; Samson E; Bink K; Höfler H; Fend F; Graw J; Atkinson MJ
Proc Natl Acad Sci U S A; 2006 Oct; 103(42):15558-63. PubMed ID: 17030811
[TBL] [Abstract][Full Text] [Related]
17. Assessment of p27 (cyclin-dependent kinase inhibitor 1B) and aryl hydrocarbon receptor-interacting protein (AIP) genes in multiple endocrine neoplasia (MEN1) syndrome patients without any detectable MEN1 gene mutations.
Igreja S; Chahal HS; Akker SA; Gueorguiev M; Popovic V; Damjanovic S; Burman P; Wass JA; Quinton R; Grossman AB; Korbonits M
Clin Endocrinol (Oxf); 2009 Feb; 70(2):259-64. PubMed ID: 18710468
[TBL] [Abstract][Full Text] [Related]
18. Mutation analysis of MEN1, HRPT2, CASR, CDKN1B, and AIP genes in primary hyperparathyroidism patients with features of genetic predisposition.
Vierimaa O; Villablanca A; Alimov A; Georgitsi M; Raitila A; Vahteristo P; Larsson C; Ruokonen A; Eloranta E; Ebeling TM; Ignatius J; Aaltonen LA; Leisti J; Salmela PI
J Endocrinol Invest; 2009 Jun; 32(6):512-8. PubMed ID: 19474519
[TBL] [Abstract][Full Text] [Related]
19. Multiple endocrine neoplasia type 1 (MEN1) gene mutations in a subset of patients with sporadic and familial primary hyperparathyroidism target the coding sequence but spare the promoter region.
Karges W; Jostarndt K; Maier S; Flemming A; Weitz M; Wissmann A; Feldmann B; Dralle H; Wagner P; Boehm BO
J Endocrinol; 2000 Jul; 166(1):1-9. PubMed ID: 10856877
[TBL] [Abstract][Full Text] [Related]
20. Identification of somatic mutations in parathyroid tumors using whole-exome sequencing.
Cromer MK; Starker LF; Choi M; Udelsman R; Nelson-Williams C; Lifton RP; Carling T
J Clin Endocrinol Metab; 2012 Sep; 97(9):E1774-81. PubMed ID: 22740705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]